A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer.
Cell Rep Med
; 4(4): 101015, 2023 04 18.
Article
in En
| MEDLINE
| ID: mdl-37075701
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Casein Kinase Ialpha
/
Prostatic Neoplasms, Castration-Resistant
Limits:
Humans
/
Male
Language:
En
Journal:
Cell Rep Med
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: